Paul Buckman - Jul 2, 2025 Form 4 Insider Report for HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)

Role
Director
Signature
/s/ Stephanie Swan, by Power of Attorney
Stock symbol
HSDT
Transactions as of
Jul 2, 2025
Transactions value $
$0
Form type
4
Date filed
7/3/2025, 08:00 PM
Previous filing
Jun 25, 2025
Next filing
Jul 30, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BUCKMAN PAUL Director C/O HELIUS MEDICAL TECHNOLOGIES, INC., 642 NEWTOWN YARDLEY ROAD, SUITE 100, NEWTOWN /s/ Stephanie Swan, by Power of Attorney 2025-07-03 0001215243

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HSDT Stock Option (Right to Buy) Award $0 +2.6K $0.00 2.6K Jul 2, 2025 Class A Common Stock 2.6K $9.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant to the Reporting Person of a stock option under the Issuer's 2022 Equity Incentive Plan. 50% of the options vested immediately upon grant, and the remaining options vest in a series of four (4) successive equal quarterly installments on the last day of each quarter starting on September 30, 2025, subject to the Reporting Person's continued service through each applicable vesting period.